Martha V Taboada, MD

Taboada Martha V
Specialties
Pediatric Endocrinology
Gender
Female

Primary Office
1131 N 35th Avenue
2nd Floor
Hollywood, FL 33021
Phone
954-265-6984
Fax:
954-981-5516
Primary Office
1150 N 35th Avenue
Suite 520
Hollywood, FL 33021
Phone
954-265-6984
Fax:
954-981-5516
Alternate Location
1865 N Corporate Lakes Blvd
Suite 1
Weston, FL 33326
Phone
954-265-6984
Fax:
954-389-4008
Alternate Location
9291 Glades Road
Suite 202
Boca Raton, FL 33434
Phone
954-265-6984
Fax:
954-981-5516

Meet the Physician

Martha Taboada, MD is board-certified in pediatrics and pediatric endocrinology. She earned her medical degree at the Universidad Del Norte, Barranquilla, Colombia, in 2002. She completed her internship and residency at the University of Kansas Medical Center in 2007. She completed her fellowship in pediatric endocrinology at Nemours Children’s Clinic, University of Florida, in 2010.

Dr. Taboada has expertise in Diabetes, growth, puberty and thyroid disorders.

Research

Professional organizations

  • The Pediatric Endocrine Society
  • The Endocrine Society

Recent publications

  • “Metabolic Effects of Oral vs. Transdermal 17B Estradiol (E2): A Randomized Clinical Trial in Girls with Turner Syndrome,” Journal of Clinical Endocrinology and Metabolism, 2013
  • “Estrogen Therapy in Turner Syndrome: Does the Type, Dose and Mode of Delivery Matter? Pediatric Endocrinology Review, 2012
  • “Pharmacokinetics and Pharmacodynamics of Oral and Transdermal 17 Beta Estradiol in Girls with Turner Syndrome,” Journal of Clinical Endocrinology and Metabolism, 2011

Presentations at Regional and National Meetings

  • A missense mutation of the thyroid hormone receptor beta (THRB) in a child with Down Syndrome (DS). Abstract presentation at LWPES/ESPE 8th Joint Meeting. New York, N.Y., USA
  • The challenge of mistaken sex assignment in an 11 year old with virilizing CAH. Abstract presentation at 2nd World Conference: Hormonal and Genetic Basis of Sexual Differentiation Disorders and Hot Topics in Endocrinology. Miami, FL
  • Pharmacokinetics (PK) and pharmacodynamics (PD) of oral and transdermal 17β estradiol (E2) in Turner Syndrome (TS). Presented at the 2011 PAS/ASPR meeting in Denver, Colorado
  • Going Beyond X and Y”, Pediatric Grand Rounds, Wolfson’s Children Hospital, Jacksonville, Fl, 2009
  • “Turner Syndrome: The Importance of Early Recognition for Improved Outcomes,” Pediatric Grand Rounds, Nemours Children’s Hospital, Orlando, Fl, 2013

Education

Education
  • Universidad Del Norte, 2002
Residencies
  • University Of Kansas Medical Center, 2007, Pediatrics
Fellowships
  • University Of Florida At Jacksonville, 2010, Pediatric Endocrinology
Certifications
  • American Board of Pediatrics-Pediatric Endocrinology
  • American Board of Pediatrics-Pediatrics

Related Physicians